UK begins testing of hormone-free male birth control pill with 16 participants
Representational image
Researchers in the United Kingdom have initiated the first-ever clinical trial for a non-hormonal male birth control pill, marking a significant step toward achieving equitable responsibility for contraception between genders.
Quotient Sciences, a Nottingham-based drug development company, has commenced the phase I trial for its groundbreaking male contraceptive, YCT-529, involving 16 British men.
Diverging from traditional hormonal methods, YCT-529 operates without hormones and inhibits sperm production by blocking access to vitamin A. Historical studies spanning over 90 years have revealed that depriving mice, rats, and monkeys of vitamin A can induce infertility, forming the basis for this pioneering approach.
Shifting the burden of responsibility
The goal of this novel pill is to empower men in preventing unintended pregnancies, challenging the historical burden placed solely on women for contraception.
&im=FitAndFill=(700,400))
National Handloom Day 2026: From Alia Bhatt to Samantha Ruth Prabhu; Actresses who celebrated India's textile heritage as brides
)
The Royals enter the Doctor Who universe: King Charles and Queen Camilla beam into Commonwealth Games in TARDIS
)
Unitree Robotics targets $9 billion valuation in landmark IPO backed by DeepSeek and Tencent
)
India names 27 sites in Arunachal Pradesh
)
Bharat Bhhagya Viddhaata OTT: When will Kangana Ranaut's film stream online?
&im=FitAndFill=(700,400))
How many soldiers operate one S-400 battery?
)
Shakib Al Hasan ready to return to Bangladesh—under one condition
)
‘Fake news’: MEA rejects report claiming India sought defence pact with Israel after Pakistan, Saudi Arabia, Turkey deal
)
Rockstar to unveil GTA 6 extended look ahead of November launch
)
Russia forms Ukrainian Volunteer Spetsnaz Brigade to fight Ukraine
)
Drug-resistant fungus that hides in hair and enters bloodstream reported in 23 US states
)
Technology transfer deal boosts India's defence manufacturing ambitions
)
Border row erupts in Europe after Ceuta crossings, Spain imposes border controls on Italy
)
Morale plummets on USS Abraham Lincoln: Are US sailors reaching a breaking point? | GRAVITAS
)
'Security can't be bought with Pakistan, Turkey deal': Iran tells Saudi Arabia
)
Baba Vanga's 2026 prophecy: 2 predictions 'already came true', 3 terrifying ones remain. Details inside
)
Colombia’s new president Abelardo de la Espriella vows to ‘defeat narco-terrorists’, signals hardline shift
&im=FitAndFill=(700,400))
New Friday OTT releases (August 7, 2026): Operation Safed Sagar, Vadhandhi, Main Vaapis Aaunga- 6 movies and TV shows on Netflix, Prime Video and more
)
Squadron Leader Bhawana Kanth scripts history as Indian Air Force gets its first woman ‘Top Gun’ pilot
)
RSS says Gen Z protests reflect genuine distress
)
Trump says Iranian school bombing photos could be AI-generated - 'I don’t think...'
)
IAF officer held for sharing sensitive information in 'honey trap' case, booked under Official Secrets Act
)
Stray Kids under scrutiny? Fans react to Grammy submission silence after BTS boycott
&im=FitAndFill=(700,400))
Why the Su-30MKI doesn't need external fuel tanks to fly vast distances
)
Jugal Hansraj reunites with Shekhar Kapur after 40 years for Masoom: The Next Generation
)
New speed limits, automatic challans: Big traffic change coming to Delhi-Meerut Expressway. All you need to know
)
India officially names 27 places in Arunachal to counter China's renaming claims
)
Trump calls White House ballroom ruling a 'national disgrace' as court says Congress approval needed
)
US sanctions Iran’s crypto network after Strait of Hormuz attacks, offers $15m bounty for intel on IRGC finance
&im=FitAndFill=(700,400))
Why the Su-30MKI is one of the heaviest fighters ever built
)
Uttarakhand young innovator builds India's own flying vehicle, conducts first test flight: WATCH
)
Chilling video shows students take cover as teen opens fire at Thai school
)
Reese Witherspoon's father hospitalised after poolside incident in Nashville: Report
Currently, male contraceptive options are limited to withdrawal, condoms, and vasectomy, while women have a broader array of choices such as the pill, coil, contraceptive injection, and female condoms or diaphragms.
Pre-clinical studies conducted by YourChoice Therapeutics, the San Francisco-based manufacturer of YCT-529, report impressive effectiveness. The pill is claimed to be 99 per cent effective and 100 per centreversible, with no discernible side effects. The method involves blocking a specific protein, diverging from the conventional hormonal approach, with the aim of making contraception more appealing and shared between partners.
Also watch |Do not use these methods for avoiding pregnancy
Gunda Georg, regents professor at the University of Minnesota's College of Pharmacy and the developer of YCT-529, who spoke to Forbes, stressed onthe significance of introducing a male contraceptive after more than 60 years since the innovation of the female birth control pill. The hormone-free approach aligns with ethical considerations, addressing the side effects women have endured from hormonal contraception over decades.
The clinical trial for YCT-529 is expected to conclude in June 2024, according to Forbes. This groundbreaking endeavor holds promise for reshaping societal norms surrounding contraceptive responsibilities and providing couples with a broader range of choices for family planning.
(With inputs from agencies)